Chronic kidney disease after heart transplantation

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1655-1662

  Hamour, Iman M ^a   Omar, Fazir ^a   Lyster, Haifa S ^a   Palmer, Andrew ^b   Banner, Nicholas R ^a,c  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Acute renal failure; Chronic kidney disease; Ciclosporin; Heart transplantation; Risk factors

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; AGE; ARTICLE; CALCULATION; CARDIAC GRAFT REJECTION; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EXPOSURE; DRUG WITHDRAWAL; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART TRANSPLANTATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROBABILITY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 65249149590     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn759     Document Type: Article

References (47)

1. Taylor DO, Edwards LB, Boucek MM et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007; 26: 769-781
2. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940
3. Myers BD, Ross J, Newton L et al. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699-705
4. Myers BD, Sibley R, Newton L et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590-600
5. Banner NR, LysterH,Yacoub MH. Clinical immunosuppression using the calcineurin-inhibitors ciclosporin and tacrolimus. Inhibitors of protein kinases and protein phosphatase. In: Pinna LA and Cohen P (eds). Handbook of Experimental Pharmacology, Vol. 167. Berlin: Springer, 2005, 321-359
6. Hamour IM, Lyster HS, Burke MM et al. Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients. Transplantation 2007; 83: 570-576
7. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
8. Vossler MR, Ni H, Toy W et al. Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation. J Heart Lung Transplant 2002; 21: 874-881
9. Lindelow B, Bergh CH, Herlitz H et al. Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol 2000; 11: 951-957
10. Greenberg A, Thompson ME, Griffith BJ et al. Cyclosporine nephro-toxicity in cardiac allograft patients - a seven-year follow-up. Transplantation 1990; 50: 589-593
11. Veillon S, Caillard S, Epailly E et al. Chronic renal failure after cardiac transplantation. Predictive factors and influences on mortality results of a monocenter study in 141 patients. Transplant Proc 2002; 34: 2819-2820
12. Diez Ojea B, Gago Gonzalez E, Diaz Corte C et al. Study of the renal function in nonrenal organ transplantation. Transplant Proc 2006; 38: 2985-2988
13. Bloom RD, Doyle AM. Kidney disease after heart and lung transplantation. Am J Transplant 2006; 6: 671-679
14. Canales M, Youssef P, Spong R et al. Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation. Am J Transplant 2006; 6: 2157-2163
15. Kim DY, Lim C, Parasuraman R et al. Renal disease burden following liver transplantation. Transplant Proc 2006; 38: 3663-3665
16. Lubitz SA, Pinney S, Wisnivesky JP et al. Statin therapy associated with a reduced risk of chronic renal failure after cardiac transplantation. J Heart Lung Transplant 2007; 26: 264-272
17. Taylor DO, Edwards LB, Boucek MM et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report - 2004. J Heart Lung Transplant 2004; 23: 796-803.
18. Rogers CA, Bonser RS, Banner NR on behalf of The Steering Group, UK Cardiothoracic Transplant Audit, Clinical Effectiveness Unit. Post operative adverse events are related to mortality after heart transplantation. J Heart Lung Transplant 2008; 27; S97
19. Satchithananda DK, Parameshwar J, Sharples L et al. The incidence of end-stage renal failure in 17 years of heart transplantation: a single centre experience. J Heart Lung Transplant 2002; 21: 651-657
20. Goldstein DJ, Zuech N, Sehgel V et al. Cyclosporine-associated end-stage nephropathy after cardiac transplantation - incidence and progression. Transplantation 1997; 63: 664-668
21. Banner NR, Yacoub MH. Cyclosporine in thoracic organ transplantation. Transplant Proc 2004; 36(2 Suppl): 302S-308S
22. Kobashigawa J, Miller L, Renlund D et al. A randomised active-controlled trial of mycophenolate mofetil in heart transplant recipients. The mycophenolate mofetil investigators. Transplantation 1998; 66: 507-515
23. McKenzie N, Keown P, Stiller C et al. Effects of cyclosporine on renal function followingorthotopic hearttransplantation. J Heart Lung Transplant 1985; 4: 400-403
24. Zietse R, Balk AH, vd Dorpel MA et al. Time course of the decline in renal function in cyclosporine-treated heart transplant recipients. Am J Nephrol 1994; 14: 1-5
25. Tedoriya T, Keogh AM, Kusano K et al. Reversal of chronic cy-closporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil. J Heart Lung Transplant 2002; 21: 976-982
26. Groetzner J, Meiser B, Landwehr P et al. Mycophenolate mofetil and sirolimusascalcineurin inhibitor-free immunosuppression for late cardiac transplant recipients with chronic renal failure. Transplantation 2004; 77: 568-574
27. Meiser B, Reichart B, Adamidis I et al. First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation. Am J Transplant 2005; 5(4 pt1): 827-831
28. Hunt J, Bedanova H, Straling RC et al. Premature termination of a prospective, open label, randomised, multicentre study of sirolimus to replace calcineurin inhibitors (CNI) in a standard care regimen of CNI, MMF and corticosteroids early after heart transplantation. J Heart Lung Transplant 2007; 26: S203
29. Brown JR, Uber PA, Mehra MR. The progressive cardiorenal syndrome in heart failure: mechanism and therapeutic insights. Curr Treat Options Cardiovasc Med 2008; 10: 342-348
30. Knight EL, Glynn RJ, Mc Intyre KM et al. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD). Am Heart J 1999; 138: 849- 855
31. Stevens LM, El Hamamsy I, Leblance M. Continuous renal replacement therapy after heart transplantation. Can J Cardiol 2004; 20: 619-623
32. Canver CC, Heisey DM, Nichols RD. Acute renal failure requiring haemodialysis immediately after heart transplantation protends a poor outcome. J Card Surg 2000; 41: 203-206
33. Ojo AO. Renal disease in recipients of nonrenal solid organ transplantation. Semin Nephrol 2007; 27: 498-507
34. Rocha PN, Rocha AT, Palmer SM et al. Acute renal failure after lung transplantation: incidence, predictors and impactonperioperative morbidity and mortality. Am J Transplant 2005; 5: 1469-1476
35. Parawade A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003; 9: 741-747
36. Odim J, Wheat J, Laks H et al. Perioperative renal function an outcome after orthotopic heart transplantation. J Heart Lung Transplant 2006; 25: 162-166
37. Ostermann ME, Rogers CA, Saeed I et al. Steering Group of the UK Cardiothoracic Transplant Audit. Pre-existing renal failure doubles 30-day mortality after heart transplantation. J Heart Lung Transplant 2004; 23: 1231-1237
38. Al Aly Z, Abbas S, Moore E et al. The natural history of renal function following orthotopic heart transplant. Clin Transplant 2005; 19: 683- 689
39. Kirsch M, Baufreton C, Naftel DC et al. Pre-transplant risk factors for death after heart transplantation: the Henri Mondor experience. J Heart Lung Transplant 1998; 17: 651-653
40. Al Naamani N, Maarouf OH, Wilt J et al. The Modification of Diet in Renal Disease (MDRD) and prediction of kidney outcomes after lung transplantation. J Heart Lung Transplant 2008; 27: 1191- 1197
41. Banner NR, Thomas HL, Curnow E et al. on behalf of the Steering Group of UK cardiothoracic Transplant Audit. The importance of cold and warm cardiac ischaemia for survival after heart transplantation, a UK national Study. Transplantation 2008; 86: 542-547
42. Tenderich G, El-Banayosy A, Rosengard B et al. Prospective multi-center European trial to evaluate the safety and performance of the organ care system for heart transplants (PROJECT). J Heart Lung Transplant 2007; 26(2S): S64
43. Santise G, Petrou M, Pepper JR et al. Levitronix as a short-term salvage treatment for primary graft failure after heart transplantation. J Heart Lung Transplant 2006; 25: 495-498
44. AL-Naamani N, Maarouf OH, Ahya VN et al. Assessment of kidney function in lung transplantation. J Heart Lung Transplant 2008; 27: 635-641
45. Harzallah K, Sellam A, Mhiri A et al. Creatinine clearance estimation after kidney transplantation: an analysis of three methods. Transplant Proc 2007; 39: 2571-2573
46. Bosma RJ, Doorenbos CR, Stegeman CA et al. Predictive performance of renal function equations in renal transplant recipients: an analysis of patient factor bias. Am J Transplant 2005; 5: 2193-2203
47. Rodrigo E, Fernández-Fresnedo G, Ruiz JC et al. Assessment of glomerular filtration rate in transplant recipients with severe renal insufficiency by Nankivell, Modification of Diet in Renal Disease (MDRD), and Cockcroft-Gault equations. Transplant Proc 2003; 35: 1671-1672